Business

Zylox-Tonbridge Hosts Investor Open Day, Showcasing Innovation Pipeline and Global Growth Strategy

Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190), a leading innovator in neurovascular and peripheral vascular interventional solutions, hosted its Investor Open Day at its Zhuhai Innovation Center, welcoming nearly 150 institutional investors and sell-side analysts.

articleZylox-tonbridge Medical Technology Co., Ltd. Class HJanuary 11, 20263/company/zylox-tonbridge-med-tech-co/news/zylox-tonbridge-hosts-investor-open-041600287
Zylox-Tonbridge Hosts Investor Open Day, Showcasing Innovation Pipeline and Global Growth Strategy

About this update from Zylox-tonbridge Medical Technology Co., Ltd. Class H

[{"type":"text","content":"HANGZHOU, China, Jan. 11, 2026 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190), a leading innovator in neurovascular and peripheral vascular interventional solutions, hosted its Investor Open Day at its Zhuhai Innovation Center, welcoming nearly 150 institutional investors and sell-side analysts.","length":323,"tagName":"p"},{"type":"text","content":"The event highlighted the Company's strategy to build a globally competitive vascular intervention platform through R&D-driven innovation, a global-scale manufacturing platform, and an expanding global commercial footprint. Through management presentations, product demonstrations and facility tours, Zylox-Tonbridge provided investors with a comprehensive view of how its innovation engine, operating platform and global commercialization capabilities are aligned to support long-term growth.","length":501,"tagName":"p"},{"type":"text","content":"A Differentiated Innovation Platform Advancing Precision Endovascular Care","length":74,"tagName":"p"},{"type":"text","content":"At the event, Zylox-Tonbridge showcased a broad portfolio of commercialized and late-stage pipeline products, reflecting the increasing depth and competitiveness of its endovascular platform across both neurovascular and peripheral vascular indications.","length":253,"tagName":"p"},{"type":"text","content":"Key products included:","length":22,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"ZYLOX Mammoth™ Large-Bore Thrombectomy Catheter, China's only 12F–18F peripheral thrombectomy catheter, designed with a proprietary flared tip to enable high-efficiency clot removal for deep vein thrombosis (DVT).","length":217,"tagName":"p"}]},{"val":[{"type":"text","content":"Feilong™ Embolization Assist Stent, the first in its category in China to utilize DFT (Drawn Filled Tubing) braided technology, enabling full-length radiopacity to enhance procedural precision and clinical confidence.","length":217,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":434,"olType":false},{"type":"text","content":"The Company also highlighted its image-guided endovascular therapy platform, centered on its intravascular optical coherence tomography (OCT) system and the ZYLOX Pantheris™ atherectomy catheter, the world's only commercially available solution enabling real-t...

More updates from Zylox-tonbridge Medical Technology Co., Ltd. Class H

The Companyglobal commercializationvascular interventionmanufacturingZylox-Tonbridgepipeline productsCompanyInnovationChinaoperating platformMedical Technologyinstitutional investors